Coronary artery calcium scoring: Difference between revisions
Jump to navigation
Jump to search
| Line 22: | Line 22: | ||
| B | | B | ||
|- | |- | ||
| 2016 European Guidelines on Cardiovascular Disease Prevention In Clinical Practice | | 2016 European Guidelines on Cardiovascular Disease Prevention In Clinical Practice <ref name="pmid27222591">{{cite journal| author=Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL et al.| title=2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). | journal=Eur Heart J | year= 2016 | volume= 37 | issue= 29 | pages= 2315-81 | pmid=27222591 | doi=10.1093/eurheartj/ehw106 | pmc=4986030 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27222591 }} </ref> | ||
| CAC may be considered as a risk factor in CV risk assessment in patients with a calculated SCORE risk between 5% to 10%. | | CAC may be considered as a risk factor in CV risk assessment in patients with a calculated SCORE risk between 5% to 10%. | ||
| IIb | | IIb | ||
Revision as of 04:04, 24 August 2017
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Tarek Nafee, M.D. [2]
Overview
Coronary Artery Calcium Scoring
Role of CAC score in Clinical Practice
Current Guidelines
| Guideline | Recommendation | ||
|---|---|---|---|
| Class | Level of Evidence | ||
| 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk [1] | If after quantitative risk assessment, a risk-based decision is uncertain, one or more of the following tools may be used to aid in decision making: family history, hs-CRP, CAC score or ABI. | IIb | B |
| 2016 European Guidelines on Cardiovascular Disease Prevention In Clinical Practice [2] | CAC may be considered as a risk factor in CV risk assessment in patients with a calculated SCORE risk between 5% to 10%. | IIb | B |
| Recommendation | |||
| ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR
2010 Appropriate Use Criteria for Cardiac Computed Tomography |
CAC would be appropriate in patients with a 10-20% 10-year risk of CHD. | Appropriate | |
| CAC would be appropriate in low risk patients (<10% 10-year risk of CHD) with a family history of premature CHD. | Appropriate | ||
| The usefulness of CAC is uncertain in patients with peripheral arterial disease or other coronary risk equivalents, or have a 10-year CHD risk greater than 20%, or who are 40 or older with diabetes. | Uncertain | ||
| CAC would be inappropriate in low risk patients (<10% 10-year risk of CHD). | Inappropriate | ||
References
- ↑ Goff DC, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB, Gibbons R; et al. (2014). "2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines". Circulation. 129 (25 Suppl 2): S49–73. doi:10.1161/01.cir.0000437741.48606.98. PMID 24222018.
- ↑ Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL; et al. (2016). "2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)". Eur Heart J. 37 (29): 2315–81. doi:10.1093/eurheartj/ehw106. PMC 4986030. PMID 27222591.